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Abstract 
Purpose: To examine the effect of divergence in patients’ socioeconomic background on their 
perspective of the roles of the pharmacist in Amman, Jordan. 
Methods: This was a single-phase observational study conducted in two different socioeconomic areas: 
Western (WA) and Eastern Amman (EA, which is of a lower socioeconomic status than WA) in March to 
May of both 2009 and 2010. A validated questionnaire was completed by patients walking into 
community pharmacies. The source of advice (clinical specialist, general practitioner, pharmacist, nurse 
or herbalist) regarding patient's disease management and medication use, as well as patients’ 
expectation of the pharmacist were investigated.  
Results: 2000 patients (mean age: 35.1 ± 13.7 years, 57.2 % males) visiting community pharmacies in 
Amman (1000 each from WA and EA) took part in the study. The majority of patients chose the 
pharmacist as the source of advice on medication use (WA, 50.8 %; EA, 53.6 %), followed by the 
clinical specialist (WA, 35.7 % vs EA, 26.9 %, p = 0.001). Other aspects of patient perspective and 
expectation of the pharmacist were also assessed; in several instances, more reliance on the 
pharmacist was observed in EA (lower socioeconomic status) than in WA.  
Conclusion: The findings of this study is important for future social pharmacy studies in the area, as it 
shows that socioeconomic status influences patient’s perception of the role of the community 
pharmacist in Amman, Jordan.  
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In recent years, the pharmacy profession is 
increasingly recognized as an important partner 
in the multidisciplinary health care in Jordan. 
Pharmaceutical care requires the pharmacist to 
be more accountable in ensuring that a patient 
achieves positive outcomes from therapy [1-4].  
The patient’s perception of the pharmacist’s role 
relative to the roles of other health care 
professionals (HCPs) is likely to be influenced by 
many factors such as patient’s socioeconomic 
status [5]. This is because the pharmacist is 
probably the only HCP that is approached for 
regular counseling without the requirement of a 
consultation fee. Yet, to the best of our 
knowledge, no previous study has been 
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conducted to examine the effect of 
socioeconomic status on patient perception of 
HCPs in Jordan, a country with divergence in the 
socioeconomic status of its inhabitants.  
 
Jordan has more than 2000 functioning 
community pharmacies distributed throughout 
the country. Amman, the capital, has 60 % of 
those pharmacies (1203). Amman is divided into 
two major areas - Western Amman (WA) which is 
relatively developed, and Eastern Amman (EA) 
which is a lower income, poverty-striken area. 
Therefore, comparing patient perceptions in 
these two areas serves two main aims. First, it 
will enable better understanding of patients’ 
expectation of the services that can be delivered 
by a community pharmacist and his role relative 
to otherHCPs in Amman, Jordan. Second, it 
would provide some insight into the influence of 
socioeconomic divergence on patient’s 





The study was undertaken over a period of 4 
months (March to May of both 2009 and 2010) in 
randomly selected community pharmacies in WA 
and EA, Jordan. All of the pharmacy students 
enrolled in the Clinical Pharmacy and 
Therapeutics 1 and 2 course units at the Applied 
Science University for the year 2009/2010 (n = 
143) assisted in carrying out this study.  
Each student approached 10 to 15 patients 
walking into a community pharmacy to purchase 
prescription medications. The pharmacies were 
randomly selected from WA and EA. The 
consent of the pharmacist in charge of the 
pharmacy was obtained before patients were 
approached. Patients that agreed to take part in 
the study provided informed oral consent.  
 
The pharmacy students were trained to carry out 
the assignment including on the issue of 
cognitive bias that can lead to social desirability 
(having respondents answering questions in a 
way that is not completely according to their true 
beliefs). Importance of preventing this bias with 
practical measures to attain true results were 
clarified and implemented. The pharmacy 
students introduced themselves as researchers, 
pharmacist in charge not being present during 
the questionnaire completion; questionnaire was 
completed outside the community pharmacy; and 
completed questionnaires were inserted in 
envelopes and sealed by the pharmacy students.  
Following questionnaire completion, the sealed 
envelopes were stamped by the pharmacist in 
charge, and returned to the principal researchers 
(EQ, IB, and NB). The principal researchers 
contacted a random sample of the pharmacies to 
verify that the study was carried out according to 
protocol.  
 
To avoid respondents confusing who is a 
pharmacist and pharmacy assistant, it was 
pointed out to them who the pharmacist was 
when completing the questionnaire. The 
questionnaire included both closed and open 
questions prepared by the principal researchers, 
and was in two parts, Part A investigated source 
of advice regarding the patient’s medication use, 
review of treatment for chronic conditions, and 
non-pharmacological measures, in addition to the 
most trusted HCPs in terms of advice on medical 
condition. Part B investigated specifically what is 
expected of the community pharmacist by the 
patient, such as time and extent of counseling, 
provision of counseling areas, home delivery of 
medications and handling of extra paid services 
such as the Medication Management Review 
(MMR) service. 
 
To ensure face validity, the questionnaire (in both 
English and Arabic languages) was evaluated by 
three academics (EQ, IB, NB) who have previous 
experience in conducting clinical studies and 
have a wide range of clinical professional 
experience. The questionnaire was then 
completed by pharmacy students (n = 15) to test 
for clarity of questions. Views and comments of 
the students were considered by the researchers 
and then incorporated where appropriate into the 
final version of the questionnaire. To assess test-
retest reliability, the questionnaire was 
administered on two occasions to 15 randomly 
selected pharmacy students and 15 community 
pharmacy customers. The second testing took 
place two weeks after the first one, and was not 
included in the final survey analysis. Test-retest 
reliability was computed using Spearman's 
correlation coefficient (r). The rho-value was 
0.84, which implies acceptable test-retest 
reliability. 
 
Respondents were asked to answer the first part 
of the questionnaire using the options ‘general 
practitioner’, ‘clinical specialist’, ‘pharmacist’, 
‘nurse’ and ‘others’. The second part of the 
questionnaire had the options ‘yes’, ‘no’, or ‘not 
sure’. There was a section inviting comments at 




Participants’ responses were encoded and the 
data were analyzed using Statistical Package for 
the Social Sciences (SPSS, version 17, Chicago, 
IL, US). Descriptive analysis was carried out to 
determine the proportion of patients who 
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selected each of theHCPs for the first part of the 
questionnaire, and proportion of patients who 
agreed or disagreed with each of the questions in 
the second part of the questionnaire. Chi square 
test was used to identify any significant 
difference among the participants’ responses for 
WA and EA, with significance defined as p ≤ 
0.05.  
 
Sample size calculation was based on the 
population of Amman (1,206,266 in the year 
2010) [6] minimum sample size of 443 was 
calculated, for a margin error of 5 %, confidence 
level of 95 %, a response distribution of 50 %, 
and an added on 15 %, since a non-parametric 
test was planned to be used in the analysis. We 
decided to collect a sample size of 2000 patients 
(1000 patients for each region), which meets the 
required minimum sample size, and gives each 
student the chance to meet and talk to at least 10 




Two thousand patients visiting community 
pharmacies in Amman, Jordan were approached 
by 143 advanced pharmacy students. Fifty seven 
percent of the patients interviewed were males 
(no significant difference between WA and EA, p 
= 0.179). Mean age of patients was 35.2 ± 13.7 
(no significant difference between WA and EA, p 
= 0.283). A majority of patients interviewed were 
university students and housewives (Table 1). 
 
Half of the WA (50.8 %) and EA (53.6 %) 
patients believed that community pharmacists 
were the HCP that provide them with advice 
most frequently on their medication use, 
including medical devices, such as asthma 
inhalers, followed by clinical specialists (Figure 
1A and B). The proportion of EA patients that 
chose pharmacist over clinical specialist was 
significantly higher than that of WA patients (p = 
0.001). 
 
In addition, we found that a majority of the 
patients tend to go back to their specialists for 
regular review of treatment for their chronic 
conditions (Figure 2A and B). The pharmacists 
came next in both areas of Amman, with more 
patients doing so than to GPs. The proportion of 
WA patients that chose specialists for treatment 
review over the pharmacist was significantly 
higher than for EA patients (p < 0.001). 
 
When it comes to patients’ trust in theHCPs, 
specialists were the most trusted by a majority of 
patients requesting advice on their medical 
conditions (WA 66.8 % vs EA 54.0 %, p < 0.001), 
followed by the GP (WA 14.6 % vs EA 21.4 %), 
and the pharmacist (WA 13.6 % vs EA 18.1 %), 
with no significant difference between the GP 
and pharmacist (p = 0.536).  
 
With regard to the use of non-pharmacological 
treatments (alternative medicine and 
complimentary medicine), the HCPs that 
discussed this form of treatment most with 
patients were the ‘traditional naturopath’ (WA 
32.5 % vs EA 36.1 %) and pharmacist (WA 31.9 
% vs. EA 33.6 %), with no significant difference 
between these two HCPs across WA and EA (p  
=  0.716). Non-pharmacological treatments were 
used by almost half of the patients (47.5 %). 
Reported non-pharmacological treatments 
include natural treatments for diabetes, 
hypertension, fungal infections, gastrointestinal 
spasms, flu, and body weight reduction. Many 
patients (77.0%) believed that complimentary 
treatments were a safer alternative to drugs and 
have less side effects. A majority of patients from 
WA (70.7 %) and EA (64.2 %) had tried herbal 
and complementary treatments (p < 0.001). Only 
a few patients did not believe in this type of 
therapy (WA 0.2 % vs EA 1.0 %). Categorization 
of the herbal treatments that were mentioned the 
most by patients indicates that they include 
ginger to treat loss of voice, herbal volatile oil for 
gastrointestinal spasm, hot extract of parsley for 
kidney stones, and various herbal medicines for 
enhancement of memory.  
 
 
Table 1: Demographic characteristics of patients in the Western (n = 1000) and Eastern (n = 1000) Amman 
areas 
 
Characteristic Western & Eastern 
Amman 
Western Amman Eastern Amman P-value (Chi 
square test) 
Age (mean ± SD) 35.13±13.73 34.57±13.72 35.65±13.73 0.283 
Gender (male:female) 1096:821 512:409 584:412 0.179 
Occupation n (%)     
- Student 449 (24.4) 233 (26.5) 216 (22.4) 0.089 
- Housewife 281(15.3) 138 (15.7) 143 (14.8)  
- Academic 135 (7.3) 53 (6.0) 82 (8.5)  
- Engineer 163 (8.8) 88 (10.0) 75 (7.8)  
- Doctor 50 (2.7) 26 (3.0) 24 (2.5)  
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Figure 1: Proportion of health care professionals that provided advice most on medication use; A = Western 

























Figure 2: Proportion of health care professionals whom patients visited most; A = Western Amman (n = 1000), 
and B = Eastern Amman (n = 1000) 
 
The second part of the questionnaire evaluated 
patients’ responses to specific questions 
regarding their expectation of the role of the 
community pharmacist in Amman. The majority 
of patients believed that community pharmacists 
should be responsible for the sales of over-the-
counter (OTC) medications without reference to 
another HCP (WA 73.4 % vs EA 78.7 %, p = 
0.017). The others either disagreed (WA 21.8 %, 
EA 18.0 %) or were not sure (WA 4.8 % vs. EA 
3.3 %). The results also show that a majority of 
patients believed that the role of the pharmacist 
with regard to prescription medications is to 
dispense them once there is a prescription (WA 
72.2 % vs EA 65.9 %, p = 0.016).  
 
A majority of patients considered provision brief 
counseling (up to 2 min) as one of the roles of 
Nurse
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GP
GP= General Practitioner
Specialist= a specialist in any clinical area
> 1 HCP = More than one health care professional 
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the community pharmacist (Figure 3). 
Furthermore, over half of the patients believed 
that pharmacists need to provide even longer 
counseling sessions (> 2 min, Figure 3}. When it 
came to paying the pharmacist for additional 
counseling services, only a small proportion of 
patients from both WA and EA agreed. No 
significant difference was found between WA and 
EA.     
 
 
Figure 3: Proportion of patients from Western and 
Eastern Amman (each n = 1000) who agreed with 
having brief (up to 2 min) counseling (A), longer (> 2 
min) more detailed counseling (B), and paid 


































Figure 4: Proportion of patients from Western and 
Eastern Amman (each n = 1000) who agreed, 
disagreed or ‘did not know’ that their medications can 
be delivered to their homes and without pharmacist 
counseling  
 
With regards to providing private counseling 
areas in pharmacies, a significantly higher 
proportion of patients from EA (54.4 %) than from 
WA (40.3 %) were in favour (p < 0.001). A few 
patients (12.2 %) from both districts of Amman 
were undecided on the need for a designated 
counseling area.  
 
A majority of patients from both WA and EA (73.4 
and 79.2 %, respectively, p = 0.86), believed that 
pharmacists should refer them back to the 
clinical specialist when necessary (i.e., when 
they were not sure about their treatment) rather 
than prescribe medicines independently. 
However, only a few patients (from both WA 
(13.1 %) and EA (13.8 %)) agreed that they 
could receive their medications from the 
pharmacist without any counseling (Figure 4). 
The proportion was significantly lower for WA 




There is growing interest in the roles expected of 
a pharmacist. Understanding these roles in the 
community setting and whether they meet the 
needs of the patient has become imperative. This 
study derives from the fact that in Jordan, 
community pharmacies are the most accessible 
primary health care facilities [10] In addition, this 
is the first study in Jordan to assess differences 
in patient perspective of the role of the 
community pharmacist based on differences in 
socioeconomic background.    
 
A majority of the Jordanian patients consider the 
community pharmacist the major contributor to 
advice on the use of medications and medical 
devices. Similar results were reported in a study 
conducted in Qatar, where over 90 % of 
respondents agreed that the community 
pharmacist is the primary source of information 
on directions on medication use [6]. The fact that 
the margin by which the pharmacist is favoured 
over the clinical specialist for this advice in EA 
was about twice that for WA is due, at least in 
part, to socioeconomic factors. The cost of a visit 
to clinical specialist is about US$40 and the 
average monthly income for a worker in Amman 
is US$500. Therefore, a direct visit to the 
community pharmacist is a significant saving. 
 
Although the role of the pharmacist in counseling 
on medication use is positive in this regard, it can 
be improved further. Previous studies conducted 
in Jordan highlighted the fact that many patients 
(23 – 40 %) self medicate, with half of these 
patients purchasing their medications at 
community pharmacies without approaching the 
pharmacist for advice or counseling [7-9].  
 
The fact that greater dependence on the 
pharmacist was seen in the EA for review of 
treatment for chronic conditions is also likely to 
be, at least in part, a socioeconomic effect. 
These findings suggest that pharmacists in lower 
socioeconomic areas have a greater 
responsibility in meeting the needs of patients 
who have chronic conditions. These results are 
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Canada where it was observed that clinical 
specialist services were comparatively under-
utilized by people living in areas of lower 
socioeconomical circumstances [10]. The fact 
that in our study pharmacists were preferred over 
GPs for review of treatment for chronic 
conditions in both districts of Amman further 
supports the positive attitude towards the role of 
the community pharmacist in Amman.  
 
The choice of specialists over pharmacists when 
it came to trust in requesting advice on medical 
conditions was less apparent in EA than WA. 
This, again, is an opportunity for pharmacists in 
EA.  
 
Although a majority of patients considered 
complementary treatment safer than traditional 
medications, patients still greatly made use of 
traditional medical treatments and therapeutic 
services. This shows that regardless of the 
perceived safety of complementary treatments by 
Jordanian patients, their use are largely 
‘complementary’ after all. The finding that 
herbalists have a major role in advising patients 
on the use of complimentary medicine highlights 
a potential problem. A previous study in Amman 
showed that most herbalists in the area are not 
educated enough, and several odd and 
unprecedented recommendations are given to 
patients [5]. This indicates that educating both 
herbalists and pharmacists on the correct use of 
herbs and complementary treatments in Jordan 
is very important [11], and that proper regulations 
and licensing are needed. In this regard, WHO 
guidelines would be a good basis for such 
regulations [12]. 
 
The present study showed that there was correct 
awareness of the responsibilities of community 
pharmacists with regard to their role when it 
came to OTCs and prescription medications. 
Most respondents stated that the community 
pharmacist should be responsible for the sale of 
OTC medications based on his/her decision, 
while the majority also said that prescription 
medications should be dispensed by the 
pharmacist only after a prescription is presented 
by the patient. 
 
The importance of patient counseling by the 
pharmacist cannot be overstressed [13]. Our 
study indicates that patients in Amman, 
regardless of socioeconomic status, 
acknowledged the importance of counseling. Yet, 
the drop in the proportion of patients who 
acknowledged the need for longer counseling 
indicates that the counseling role of the 
pharmacist should be given greater attention in 
the undergraduate pharmacy curriculum, via 
HCPs’ continuous educational programs, and 
wellbeing awareness programs. 
 
A majority of respondents, regardless of their 
socioeconomic background, did not welcome 
paid pharmaceutical care services, due probably 
to their unwillingness to pay additional costs to 
the community pharmacist and their lack of 
awareness of the benefits of such services to 
their health status. There is a growing awareness 
of the importance of having a private counseling 
area in the pharmacy [14].  Lacking private 
counseling areas in the pharmacy is considered 
a barrier that hinders pharmacists from fulfilling 
their role fully [15]. Yet, in the current study, a 
considerable proportion of patients either did not 
agree with or were not sure of the need for these 
areas. These results indicate that enlightening 
both pharmacists and patients on the importance 
of a private counseling area is vital.  
 
The fact that a majority of patients do not want 
medications delivered to their homes may be 
positive in that they want more than just their 
medications from the pharmacist. Having a 
significantly lower proportion of WA patients 
disagreeing with the idea may be due to previous 
exposure of the patients in this district to such 
services, and hence familiarity with it. 
 
There are several points of strength in this study. 
First, the sample size (2000 patients, 1000 from 
each district of Amman) is very good compared 
with previous similar studies conducted in Jordan 
(n = 1650) [16] and other countries around the 
world (n = 100 to 600) [17,18]. This large sample 
size promotes the generalizability of the findings 
of this study.  
 
Limitations of the study 
 
A limitation of this study is that patients are likely 
to have responded to the questionnaire without 
distinguishing between the community 
pharmacist and the pharmacy technician with 
whom the majority of the patient deal with in 
Amman. Pharmacy technicians only receive a 
middle level professional education and are 
licensed to dispense prescription drugs under the 
supervision of the pharmacist. We, however, 
tried to minimize this issue during the study by 
stating the difference between the two categories 
of personnel to the patient at the time of 




The results of this observational study are 
important for future social pharmacy studies 
since they reveal a clear socioeconomic 
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influence on patient perspective of the role of the 
community pharmacist relative to those of other 
HCPs. The study reveals a greater appreciation 
of the pharmacist’s role among people of lower 
socioeconomic status. Furthermore, our findings 
indicate a positive patient perception of the roles 
of the community pharmacist in Amman and that 
these roles can be further enhanced for the 
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